Contrarian Corpus
activist press release follow up
2016-03-21 · 1 pages

Valeant Pharmaceuticals International, Inc. VRX

N 1 Narrative
V 2 Visual
C 1 Craft
Source URL unavailable

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns.

Notes

One-page IR notice from Pershing Square Holdings, Ltd. pointing investors to a Valeant press release hosted at ir.valeant.com. No thesis content, no argument, no data — purely a forwarding/communication notice. Filename prefix '2014-09' is misleading: the document body is dated 'Amsterdam, 21 Mar. 2016' and references Valeant's 03-21-2016 press release (the period when CEO Michael Pearson's departure and going-concern/10-K issues were being disclosed). Classified as follow_up in the broader Pershing Square long-Valeant campaign. Minimal visual craft — plain Word-doc layout with one hyperlink.